Press Release: Psyence, Newcourt Deal Would Create New Palliative Care Psychedelics Company

A new, publicly traded company devoted to exploring the use of psychedelics in palliative care is in development. Psyence Biomed, a subsidiary of the Canadian biotech company Psyence Group Inc., has signed a definitive business combination agreement with Newcourt Acquisition Corp. (NASDAQ: NCAC) to create the new organization. Psyence Biomed expects to receive a minimum […]


Go to Source

Powered by WPeMatico